Dexpramipexole, an investigational orally-bioavailable synthetic amino-benzothiazole, was first developed as a treatment for amyotrophic lateral sclerosis (ALS) by Knopp Biosciences. Although it ...
Anti-mitotic therapies that target tubulin are effective and widely used in treating cancer, but they have limitations related to the role of tubulin in the cytoskeleton of normal cells.